Seyed Hamdollah Mosavat

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Major Depressive Disorder

Top Venues

International journal of psychiatry in medicine

Phytotherapy research : PTR

This page only lists publications with an associated author ORCID identifier.

Publications

Azadeh Nejati, Amir Bazrafshan, Seyed Hamdollah Mosavat
Agomelatine efficacy in treatment resistant obsessive-compulsive disorder: A randomized controlled trial. International journal of psychiatry in medicine 59 (5) (2023)
Azadeh Nejati, Amir Bazrafshan, Seyed Hamdollah Mosavat
Agomelatine efficacy in treatment resistant obsessive-compulsive disorder: A randomized double-blind clinical trial. International journal of psychiatry in medicine (2023)
Jamshid Ahmadi, Arash Mansoori, Seyed Hamdollah Mosavat, Amir Bazrafshan
Comparison of ketamine with buprenorphine as adjunctive therapy in the treatment of comorbid major depressive disorder and opium use disorders: A randomized controlled trial. International journal of psychiatry in medicine (2023)
Jamshid Ahmadi, Arash Mansoori, Seyed Hamdollah Mosavat, Amir Bazrafshan
Comparison of ketamine with buprenorphine as adjunctive therapy in the treatment of comorbid major depressive disorder and opium use disorders: A randomized controlled trial. International journal of psychiatry in medicine 59 (5) (2023)
Nematollah Rostami, Seyed Hamdollah Mosavat, Ghazaleh Heydarirad, Roya Arbab Tafti, Mojtaba Heydari
Efficacy of topical Citrullus colocynthis (bitter apple) extract oil in chemotherapy-induced peripheral neuropathy: A pilot double-blind randomized placebo-controlled clinical trial. Phytotherapy research : PTR 33 (10) (2019)
Mohammad Reza Ardakani Movaghati, Mahdi Yousefi, Seyed Ahmad Saghebi, Mahmoud Sadeghi Vazin, Aida Iraji, Seyed Hamdollah Mosavat
Efficacy of black seed (Nigella sativa L.) on kidney stone dissolution: A randomized, double-blind, placebo-controlled, clinical trial. Phytotherapy research : PTR 33 (5) (2019)